PROTALIX BIOTHERAPEUTICS INC's ticker is and the CUSIP is 74365AAD3. A total of 7 filers reported holding PROTALIX BIOTHERAPEUTICS INC in Q3 2017. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2018 | $1,509,000 | -55.7% | 1,742,000 | -53.4% | 0.02% | -54.5% |
| Q1 2018 | $3,410,000 | -3.8% | 3,742,000 | 0.0% | 0.04% | +22.2% |
| Q4 2017 | $3,544,000 | +14.8% | 3,742,000 | 0.0% | 0.04% | +5.9% |
| Q3 2017 | $3,088,000 | -28.3% | 3,742,000 | 0.0% | 0.03% | -38.2% |
| Q2 2017 | $4,307,000 | -2.8% | 3,742,000 | +33.8% | 0.06% | -20.3% |
| Q1 2017 | $4,432,000 | -2.3% | 2,796,000 | -48.3% | 0.07% | +16.9% |
| Q4 2016 | $4,537,000 | – | 5,408,000 | – | 0.06% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| HIGHBRIDGE CAPITAL MANAGEMENT LLC | 20,914,000 | $22,064,000 | 0.88% |
| WHITEBOX ADVISORS LLC | 5,000,000 | $4,857,000 | 0.16% |
| ANGELO GORDON & CO., L.P. | 1,397,000 | $1,357,000 | 0.12% |
| UBS OCONNOR LLC | 8,000,000 | $7,840,000,000 | 0.11% |
| INGALLS & SNYDER LLC | 500,000 | $490,000 | 0.02% |
| CITIGROUP INC | 7,832,000 | $7,608,000 | 0.01% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |